An antibiotic alternative for calf scours.
Amplimune, mycobacterium cell wall fraction (MCWF) immunostimulant, is USDA-approved for the reduction of clinical signs and mortality associated with K99 E. coli diarrhea in neonatal calves.
Amplimune is a USDA-approved immunotherapeutic agent for bovine infectious disease.
Amplimune is recommended as a one-time immunotherapeutic treatment for the reduction of clinical signs and mortality associated with E. coli K99 diarrhea in neonatal calves.
Studies have shown that a single, 1mL dose of Amplimune can induce an immediate innate immune response in the neonatal calf.
Amplimune is a low volume, single-dose therapy. It is available in
5-dose, 20-dose, and 100-dose vials.
Learn More
